SOPHARMA AD (97/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 1 September 2023.
Report no 97/2023
- 04.09.2023, 14:14
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (96/2023) Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exe
Report no 96/2023- 30.08.2023, 13:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (95/2023) Consolidated financial report according to IFRS as at 30 June 2023
Report no 95/2023- 29.08.2023, 13:53
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (94/2023) Completion of the infusion conversion procedure of "Biopharm Engineering" AD
Report no 94/2023- 23.08.2023, 14:21
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (93/2023) Sales revenues for July 2023
Report no 93/2023- 21.08.2023, 13:41
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (91/2023) Individual financial report according to IFRS as at 30 June 2023
Report no 91/2023- 31.07.2023, 13:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (90/2023) "Sopharma" AD starts the payment of the 2022 dividend on July 31, 2023
Report no 90/2023- 26.07.2023, 13:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (89/2023) Sales revenues for June 2023
Report no 89/2023- 20.07.2023, 13:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (88/2023) Initiation of negotiations for potential acquisition of Pharmanova, Republic of Serbia
Report no 88/2023- 14.07.2023, 16:13
- Kategoria: Biznes i finanse
- Źródło: ESPI
